The selective estrogen receptor modulator (SERM) raloxifene…
The selective estrogen receptor modulator (SERM) raloxifene (Evista®) acts as an estrogen agonist at various sites throughout the body, such as bone, but as an estrogen antagonist at other sites. This agonist/antagonist combination results in a variety of adverse events including:
Read DetailsTwo patients have an SpO₂ of 88%. Patient A has pneumonia wi…
Two patients have an SpO₂ of 88%. Patient A has pneumonia with low V/Q regions. Patient B has extensive alveolar collapse with significant intrapulmonary shunt. Why might supplemental oxygen produce a greater improvement in Patient A?
Read Details